Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared a post on LinkedIn:
“We are living in a moment of incredible progress in oncology.
But the announcements only tell part of the story. I’m launching a newsletter called “Beyond the Breakthroughs” to look beneath and beyond the headlines and understand the full oncology ecosystem. I want to explore the larger forces and innovations driving these advances, where progress is and isn’t reaching patients, and what comes next.
The first edition is about survivorship. As cancer survival rates rise, more and more people are facing a new challenge: how to thrive during and after cancer treatment. Supporting patients through and beyond cancer means thinking differently about access, long-term care, and the full experience of living with the disease. We need to be just as intentional about how we support that part of their journey. As we head into upcoming oncology meetings and forums, let’s put survivorship on equal footing with diagnosis and treatment.
You can read the first edition and subscribe to the newsletter. I welcome your thoughts on survivorship and ideas for future topics here.”
Other articles featuring Mohit Manrao.